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Abstract
Introduction and hypothesis After sacrocolpopexy, intra-
abdominal pelvic abscesses are often managed with in-
travenous antibiotics, excision of the mesh involved, and
debridement of compromised tissue.
Methods and results Three cases of successful management
of pelvic abscesses after sacrocolpopexy using long-term an-
tibiotics and percutaneous drainage of intra-abdominal ab-
scesses without removing the mesh are presented.
Conclusions In selected patients who have undergone
sacrocolpopexy, with careful counseling, conservative man-
agement of pelvic abscesses with percutaneous drainage and
long-term antibiotic treatment without the surgical excision of
the mesh may play a role.
Keywords Abscess . Antibiotics . Drainage . Sacral
colpopexy . Sacrocolpopexy .Mesh
Introduction
Sacrocolpopexy has become the gold standard for the man-
agement of apical vaginal prolapse. In spite of prophylactic
antibiotics and a careful surgical technique, pelvic abscesses
remain disconcerting complications of pelvic reconstructive
surgery. Reports indicate that mesh-related infection is an
uncommon complication of pelvic organ prolapse repair:
0.7–8.0 % for vaginal mesh placement [1] and 0.3 % after
laparoscopic mesh placement sacrocolpopexy [2]. When in-
fection occurs after the placement of a mesh, such as in
sacrocolpopexy, treatment usually involves resection of the
mesh. Most published literature is based on case reports of
treatment strategies and thus it is difficult to reach a conclu-
sion regarding a standard treatment based on what is pub-
lished. With the incorporation of type I, lightweight polypro-
pylene mesh for sacrocolpopexy, however, it is possible that
mesh resection may not be required in the face of a pelvic
abscess. There are minimal data to necessarily support mesh
resection for the treatment of pelvic abscess after vaginal mesh
placement in all cases.
General surgeons have begun to investigate conservative
management of abscesses associated with hernia mesh with
significant success in selected patients [3]. These data have yet
to be extrapolated to female pelvic reconstructive surgery. In
three cases treated from one institution, performed by the
same experienced surgeon (performing approximately 50
sacrocolpopexies per year) from 2012 to 2015, three patients
with pelvic abscesses following sacrocolpopexy were suc-
cessfully managed by CT-guided percutaneous abscess drain-
age followed by long-term broad-spectrum antibiotics. All our
patients had received antibiotic prophylaxis at the time of the
induction of anesthesia and the regimen was based on the
American College of Obstetrics and Gynecology guidelines
[4]. Each patient was administered cefazolin 2 g intravenously
1 hour before the skin incision. For surgery lasting more than
3 h, an additional intra-operative dose of cefazolin was given.
Despite the fact that the patients underwent different ap-
proaches for their sacrocolpopexy, the same standard surgical
techniques were used in all three patients including peritoneal
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covering of the mesh. The vaginal cuff was closed using V-
Loc suture by Covidien, an absorbable barbed suture. The
type I lightweight polypropylene mesh was attached to the
vagina with Gore-Tex sutures. When a pelvic abscess did
occur, each patient was extensively counseled and offered all
treatment modalities (including surgery and mesh excision),
and these three patients opted for management with drainage
and intravenous antibiotics. The intravenous antibiotics were
withheld until interventional radiology drainage was complet-
ed and the drain aspirate sent for culture. Institutional review
board approval was not requested as this case series does not




A 49-year old woman, G6P4, with stage 3 uterovaginal pro-
lapse underwent total abdominal hysterectomy, abdominal
sacrocolpopexy with lightweight type 1 polypropylene mesh
and Burch urethropexy. She presented 1-week post-operative-
ly with worsening pelvic pain and vaginal bleeding. Her tem-
perature on presentation was 99.2 °F with a white blood cell
count (WBC) of 11,200. Other vital signs were within normal
limits. A CTscan of the abdomen/pelvis revealed an 11 × 9 cm
pelvic abscess with extensive inflammation involving the sig-
moid colon without evidence of bowel perforation. This find-
ing prompted CT-guided drainage of the abscess, placement of
a Jackson Pratt drain, and treatment with broad-spectrum an-
tibiotics (piperacillin/tazobactam) for 9 days as per an infec-
tious disease consultation based on organism sensitivity. The
isolated organisms were polymicrobial. The patient was
discharged home on oral levofloxacin and metronidazole for
16 days, as recommended by the infectious disease consultant.
A follow-up CT scan of the abdomen/pelvis demonstrated
complete resolution of the abscess before discontinuing the
oral antibiotics. The patient’s 3-month follow-up examination
revealed excellent vaginal support with no evidence of infec-
tion or mesh extrusion. The patient’s 6-month follow-up
examination demonstrated excellent vaginal support and
superficial, asymptomatic mesh extrusion managed by
excision as an office procedure. The patient is presently
sexually active at 2 years post-surgery and is without
pain or further mesh extrusion.
Case 2
A 56-year-old woman, G0, with stage 2 uterovaginal prolapse
underwent robotic supracervical hysterectomy and
sacrocolpopexy with lightweight type 1 polypropylene mesh.
She presented 5 days post-operatively with fever of 101 °F
and malaise. Her other vital signs were within normal limits
and WBC was 13,000. A CT scan of the abdomen/pelvis
demonstrated a 7.4 × 4.3 cm pelvic abscess and no evidence
of bowel perforation. She underwent CT-guided drainage of
the abscess, placement of a Jackson Pratt drain, and was
started on broad-spectrum antibiotics (ampicillin/sulbactam
and vancomycin). She was subsequently treated with
piperacillin/tazobactam and vancomycin as per the infectious
disease recommendation after identification and sensitivity
studies of the infectious organism (Bacteroides fragilis). She
was then discharged on hospital day #4 on oral levofloxacin
and metronidazole for 21 days as per infectious disease rec-
ommendation. A CTscan of the abdomen/pelvis showed com-
plete resolution of the abscess before the oral antibiotics were
discontinued. The patient demonstrated excellent vaginal sup-
port at her 6-month follow-up visit. The patient reported
being able to have intercourse without pain at the 2-year
post-operative follow-up.
Case 3
A 54-year-old woman, G5P4, with stage 3 vaginal prolapse
underwent robotic sacrocolpopexy with lightweight type 1
polypropylene mesh, tension-free vaginal tape, and posterior
repair. She presented 2 weeks post-operatively with abdomi-
nal pain and a WBC count of 16,000. She was afebrile with
otherwise normal vital signs. A CT of the abdomen/pelvis
demonstrated an 8.5 × 5.6 and 2.6 × 2.3 pelvic abscess, with
no evidence of bowel injury (Fig. 1). The patient was offered
surgical excision of the mesh, which she adamantly declined.
She underwent CT-guided drainage of the abscesses and was
discharged home on oral levofloxacin and metronidazole as
Fig. 1 From patient #3. A sagittal midline image from the initial oral and
intravenous contrast-enhanced CT. This demonstrates the rounded
posterior pelvic fluid collection, 8.5 × 5.6 × 2.6 × 2.3 cm, with minimal
marginal enhancement, consistent with an abscess (arrows)
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per infectious disease recommendation based on the organ-
ism’s sensitivity (Fig. 2). The isolated pathogens were:
Citrobacter freundii, Streptococcus milleri group, and
Bacteroides fragilis. However, the patient did not complete
the 14-day course of antibiotics. She subsequently presented
to an outside hospital with abdominal pain and was diagnosed
with a small bowel obstruction. She required an exploratory
laparotomy and a small bowel resection for a compromised
bowel, in addition to drainage of multiple abscesses. There
was no evidence of iatrogenic bowel injury from the
sacrocolpopexy reported by the operating surgeon. The pa-
tient was treated with intravenous vancomycin and
meropenem as per the infectious disease recommendation.
The antibiotic regimen was changed to ertapenem based on
the sensitivity report. The isolated pathogens were
Escherichia cloacaeand Escherichia aerogenes. The patient
was discharged home on intravenous ertapenem to continue
for 2 additional weeks. She failed to continue taking the intra-
venous antibiotic, yet still declined surgical intervention. A
follow-up CT scan demonstrated interval resolution of the
pelvic abscess (Fig. 3); however, she was re-admitted 2 weeks
after discharge with a recurrent pelvic abscess with no bowel
perforation, which was again treated with percutaneous drain-
age and a 3-week course of inpatient intravenous antibiotics.
The isolated pathogen was Clostridium tertium. A CT scan at
that time demonstrated complete resolution of her abscesses.
Of note, conservative treatment was chosen because the pa-
tient was a poor surgical candidate as per her general surgery
consultation, in addition to her refusal to undergo additional
surgery. At her 3, 6, and 12-month follow-up examinations,
her vagina was noted to be well supported and had no
evidence of mesh extrusion or infection. The patient did report
dyspareunia at the 1-year follow-up.
Discussion
We present three different cases of complicated post-operative
pelvic abscesses following sacrocolpopexy, one patient with
concomitant total abdominal hysterectomy, another with
supra-cervical hysterectomy, and the third without hysterecto-
my (Table 1). All were successfully managed without resec-
tion of the sacrocolpopexy mesh. There was no evidence of
mesh erosion into the visceral organs and only case #1 had
superficial vaginal mesh extrusion.
The likely etiology of the infections is unknown as the
cultured pathogens were all different. Standard management
of an abdominal or pelvic abscess after pelvic reconstructive
surgery with mesh has previously been focused on total exci-
sion of the mesh, drainage of the abscess, and intravenous
antibiotics [5]. Little consideration has been given to a possi-
ble role of non-operative management in selected patients.
Unlike traditional management, our patients were treated
using radiologically guided percutaneous drainage followed
by continuous broad-spectrum antibiotics, without excision
of the mesh. This resulted in complete resolution of the pelvic
abscesses and prevention of further surgical morbidity, with
no recurrence of vaginal prolapse.
When considering the non-operative treatment of pelvic
abscesses after sacrocolpopexy, certain unknown factors
should be kept in mind. Specific antibiotic regimens and
lengths of treatment are uncertain, and the identification of
Fig. 2 From patient #3. Transverse delayed post-contrast CT of the
pelvis. The patient is in a prone position. There has been interval
placement of a right-sided transgluteal drainage catheter (arrowhead) in
to the posterior pelvic abscess (arrow), which was also seen in Fig. 1
Fig. 3 From patient #3. A sagittal midline image following catheter
removal and long-term therapy with broad-spectrum antibiotics. There
is interval resolution of the abscess previously seen in Fig. 1. The
sigmoid is no longer displaced from the posterior pelvis
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appropriate patients for this management. In our patients, the
choice and duration of the antibiotics was based on the rec-
ommendations by an infectious disease consultant.
Conservative management may play a role in a subset of pa-
tients with infected mesh, to avoid further surgical morbidity.
There is an established precedent in the general surgery liter-
ature for the conservative management of infected hernia
meshes when the following clinical criteria apply:
1. Infection must be a localized abscess with no evidence of
sepsis
2. No associated bowel injury must exist
3. No co-morbidity must be present that would indicate a
poor outcome (e.g., immunosuppression) [6]
The patients in this case series demonstrated the criteria
required to consider conservative treatment for a patient with
a pelvic abscess after sacrocolpopexy with type 1 polypropyl-
ene mesh. Specifically, they had no bowel injury, they had a
localized collection of purulent material amenable to percuta-
neous drainage, no evidence of sepsis, and no major co-mor-
bidities. In our three patients, there was no evidence of bowel
injury on their physical examination and evaluation by CT
scan with oral/intravenous contrast medium. The third patient
underwent a laparotomy with bowel resection for bowel ob-
struction, not related to any previous iatrogenic injury.
Regarding the risk factors for the development of abscesses,
the most likely cause of the abscess for patients #1and #2 is
vaginal contamination from concurrent hysterectomy.
Bacterial vaginosis has been associated with post-
hysterectomy cuff cellulitis/infection due to the alteration of
vaginal flora. Also, any laparotomy may be responsible for
subsequent infection secondary to contaminating skin bacteria
[7]. Patient #3 may have developed a hematoma that was
secondarily infected.
Most research in the treatment of mesh infections has been
done in general surgery patients who underwent mesh place-
ment for ventral abdominal wall and inguinal hernias. The
recommended management of mesh infections in this setting
has been intravenous antibiotics, complete excision of the
mesh, and drainage of all purulent collections [8]. In spite of
the fact that it is rare to salvage an abdominal wall-infected
mesh, there have been attempts to leave the mesh in situ and
treat the infection by percutaneous drainage of any abscess
along with intravenous antibiotics. Aguilar et al. [6] recently
reported three patients with infected mesh secondary to local-
ized abscesses salvaged after laparoscopic ventral hernia re-
pair with the use of percutaneous drainage, antibiotic irriga-
tion, and intravenous antibiotics. All patients have remained
free of clinical signs of infection following the completion of
this therapy. Aguilar et al. [6] concluded: BInfected mesh even
with an abscess after laparoscopic ventral herniorrhaphy
Table 1 Comparison of patient characteristics
Patient #1 #2 #3
Body mass index 30.8 25.8 25.2













Burch urethropexy None Mid-urethral retropubic tension-free vaginal tape sling
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without systemic sepsis may be amenable to non-operative
treatment.^ Therefore, this conclusion led to the possibility
that patients with a pelvic abscess after colpopexy may also
be treated with percutaneous drainage followed by intrave-
nous antibiotics, with the results possibly being retention of
the prosthetic mesh in carefully selected patients.
In 1994, Amid et al. [9] was able to classify synthetic ma-
terials based on their properties, including pore size and fiber
type [9]. This is of significance when considering a synthetic
prosthesis for pelvic organ reconstruction. The advantageous
properties of the mesh chosen should include: ease of use;
facility of incorporating the host tissue with reduced risk for
erosion, infection, and extrusion; and non-carcinogenicity.
Monofilament, macroporous polypropylene mesh (referred
to as type I or Blightweight^) is the synthetic material currently
preferred for use in pelvic floor reconstruction and the large
pore size (>75 μm) allows for in-growth of the mesh by mac-
rophages, fibroblasts, and blood vessels. The resulting infil-
tration of the mesh that ultimately resembles and functions as
native tissue promotes sound support for reconstruction and
decreases the likelihood of infection [5]. Gore-Tex sutures are
monofilament and microporous. There is no evidence in a
review of the literature that these sutures have been reported
to increase the likelihood of infection, unlike its counterpart,
Gore-Tex mesh.
Although the incidence of pelvic abscesses after
sacrocolpopexy is uncommon, the morbidity related to the
necessity for mesh excision is significant. We have presented
three cases of pelvic abscess after sacrocolpopexy performed
via different surgical routes, using lightweight type 1 polypro-
pylene mesh. All three infections resolved with percutaneous
drainage of abscesses and intravenous and oral antibiotics
(one patient requiring multiple treatments). It has been the
standard of care to excise the mesh prosthesis if an abscess
is present for the treatment of mesh infection. We have dem-
onstrated that this may not be necessary in selected patients. A
limitation of this paper is the small number of patients and
follow-up of only 2 years. As reported by Collins et al. [10],
infectious morbidities associated with mesh can occur many
years after the surgery and a long-term follow-up will be nec-
essary to conclude that conservative treatment is a viable op-
tion in a sub-group of patients. Also, larger studies are needed
before this treatment can be considered a safe and effective
modality. Questions to be answered in the future include the
following. What are the criteria for patient selection? What is
the appropriate number of attempts at percutaneous drainage?
How do we initially choose an antibiotic and its length of
treatment? When these questions are finally answered, percu-
taneous drainage of mesh-associated abscesses in pelvic re-
constructive surgery may well become an accepted modality,
resulting in markedly decreased patient morbidity.
Compliance with ethical standards
Conflicts of interest None.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
1. Falagas ME, Velakoulis S, Iavazzo C, Athanasiou S. Mesh-related
infections after pelvic organ prolapse repair surgery. Eur J Obstet
Gynecol Reprod Biol. 2007;134(2):147–56.
2. Stepanian A, Miklos J, Moore R, Mattox T. Risk of mesh extrusion
and other mesh-related complications after laparoscopic sacral
colpopexy with or without concurrent laparoscopic-assisted vaginal
hysterectomy: experience of 402 patients. J Minim Invasive
Gynecol. 2008;15(2):188–96.
3. Alston D, Parnell S, Hoonjan B, Sebastian A, Howard A.
Conservativemanagement of an infected laparoscopic hernia mesh:
a case study. Int J Surg Case Rep. 2013;4(11):1035–7.
4. ACOG Committee on Practice Bulletins–Gynecology. ACOG
practice bulletin No. 104: antibiotic prophylaxis for gynecologic
procedures. Obstet Gynecol. 2009;113(5):1180–9.
5. Shah HN, Badlani GH. Mesh complications in female pelvic floor
reconstructive surgery and their management: a systematic review.
Indian J Urol. 2012;28(2):129–53.
6. Aguilar B, Chapital AB, Madura 2nd JA, Harold KL. Conservative
management of mesh-site infection in hernia repair. J Laparoendosc
Adv Surg Tech A. 2010;20(3):249–52.
7. Soper DE, Bump RC, Hurt WG. Bacterial vaginosis and
trichomoniasis vaginitis are risk factors for cuff cellulitis after
abdominal hysterectomy. Am J Obstet Gynecol. 1990;163:
1016–21. discussion 1021–3.
8. Kuo YC, Mondschein JI, Soulen MC, Patel AA, Nemeth A,
Stavropoulos SW, et al. Drainage of collections associated
with hernia mesh: is it worthwhile? J Vasc Interv Radiol.
2010;21(3):362–6.
9. Amid PK, Shulman AG, Lichtenstein IL, Hakakha M. Biomaterials
for abdominal wall hernia surgery and principles of their applica-
tions. Langenbecks Arch Chir. 1994;379(3):168–71.
10. Collins SA, Tulikangas PK, Lasala CA, Lind LR. Complex sacral
abscess 8 years after abdominal sacral colpopexy. Obstet Gynecol.
2011;118:451–4.
Int Urogynecol J
